Related Experiment Video
Updated: Aug 1, 2026
07:17
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
Published on: May 9, 2018
Prostate brachytherapy--the community hospital experience
B Percarpio1, P Sanchez, P Kraus
1Department of Radiation Oncology, St. Mary's Hospital, Waterbury, USA.
Connecticut Medicine
|October 31, 2000
Summary
Prostate brachytherapy, a radioactive seed implantation treatment, shows survival rates comparable to other methods in community hospitals. Side effects like urinary issues and proctitis are temporary and resolve within 24 months.
Area of Science:
- Oncology
- Urology
- Medical Physics
Background:
- Localized prostate cancer treatment options include brachytherapy.
- Brachytherapy involves radioactive seed implantation under ultrasound guidance.
- Community hospital programs offer accessible cancer care.
Purpose of the Study:
- To evaluate the efficacy and safety of a community hospital-based prostate brachytherapy program.
- To compare survival outcomes of this program with larger series.
- To assess the incidence and duration of side effects.
Main Methods:
- Retrospective analysis of the initial 100 patients treated with prostate brachytherapy.
- Ultrasound-guided radioactive seed implantation.
- Follow-up for overall survival and disease-free survival.
Main Results:
- Survival figures comparable to radical prostatectomy and larger brachytherapy series.
- Common side effects: nocturia, urinary frequency, dysuria, proctitis.
- Side effects decreased to <10% by 12-24 months post-implantation.
Conclusions:
- Prostate brachytherapy is effective and safe in a community hospital setting.
- Comparable survival outcomes support its use.
- Transient side effects are manageable.
